NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective-Reference-Cited by-同舟云学术

NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective

Published:2016-01 Issue:4 Volume:469 Page:1012-1020
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Sandanger Ø.,Gao E.,Ranheim T.,Bliksøen M.,Kaasbøll O.J.,Alfsnes K.,Nymo Ståle H.,Rashidi A.,Ohm I.K.,Attramadal Håvard,Aukrust P.,Vinge L.E.,Yndestad A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference32 articles.

1. How and when do myocytes die during ischemia and reperfusion: the late phase;Baines;J. Cardiovasc Pharmacol. Ther.,2011

2. The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment;Garg;Catheter Cardiovasc Interv.,2008

3. Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor;Vilahur;Front. Physiol.,2014

4. Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain;Bryan;J. Immunol.,2009

5. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression;Bauernfeind;J. Immunol.,2009

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Impact of Bioactive Compounds as NLRP3 Inflammasome Inhibitors: An Update;Current Pharmaceutical Biotechnology;2024-10

2. Inhibitors of NLRP3 Inflammasome Formation: A Cardioprotective Role for the Gasotransmitters Carbon Monoxide, Nitric Oxide, and Hydrogen Sulphide in Acute Myocardial Infarction;International Journal of Molecular Sciences;2024-08-26

3. Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond;Basic Research in Cardiology;2024-06-27

4. Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities;Circulation Research;2024-06-07

5. Initial Despair and Current Hope of Identifying a Clinically Useful Treatment of Myocardial Reperfusion Injury: Insights Derived from Studies of Platelet P2Y12 Antagonists and Interference with Inflammation and NLRP3 Assembly;International Journal of Molecular Sciences;2024-05-17